Sensei Biotherapeutics In... (SNSE)
0.44
0.01 (2.09%)
At close: Mar 04, 2025, 1:06 PM
Sensei Biotherapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 13.01M | 17.8M | 7.16M | 16.6M | 251K | 653K |
| Short-Term Investments | 52.75M | 89.32M | 140.46M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 86K | 63K | 39K | 86K | 447K | 447K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.49M | 1.47M | 921K | 3.48M | 251K | 627K |
| Total Current Assets | 67.25M | 108.59M | 148.54M | 20.08M | 502K | 1.28M |
| Property-Plant & Equipment | 7.04M | 9.72M | 4.64M | 1.27M | 268K | 123K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 7.12M | 9.79M | 4.68M | 1.35M | 715K | 570K |
| Total Assets | 74.37M | 118.38M | 153.22M | 21.43M | 1.22M | 1.85M |
| Account Payables | 1.69M | 4.47M | 2.46M | 3.88M | 3.45M | 1.11M |
| Deferred Revenue | n/a | -4.47M | n/a | -32K | 2.08M | 652K |
| Short-Term Debt | 2.44M | 4.26M | 1.36M | 32K | 16.05M | 696K |
| Other Current Liabilities | 1.51M | 331K | 1.07M | 916K | 2.21M | 859K |
| Total Current Liabilities | 5.64M | 9.07M | 4.89M | 4.83M | 21.71M | 2.66M |
| Long-Term Debt | 3.77M | 5.9M | 1.67M | 653K | n/a | 4.05M |
| Other Long-Term Liabilities | 67K | n/a | 149K | 52K | 48.16M | 48.62M |
| Total Long-Term Liabilities | 3.84M | 5.9M | 1.82M | 73.04M | 48.16M | 52.67M |
| Total Liabilities | 9.48M | 14.97M | 6.71M | 77.87M | 69.88M | 55.33M |
| Total Debt | 6.21M | 8.03M | 2.35M | 567K | 16.05M | 4.75M |
| Common Stock | 3K | 3K | 3K | n/a | 2K | 2K |
| Retained Earnings | -231.9M | -197.79M | -149.21M | -112.41M | -92.31M | -75.57M |
| Comprehensive Income | -209K | -1M | -333K | n/a | -2K | -314K |
| Shareholders Equity | 64.89M | 103.41M | 146.51M | -56.44M | -68.66M | -53.48M |
| Total Investments | 52.75M | 89.32M | 140.46M | n/a | n/a | n/a |